| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5879393 | Journal of Pain and Symptom Management | 2015 | 8 Pages |
Abstract
Hospice patients with hematologic malignancies are more seriously ill at the time of admission, with worse functional status and shorter lengths of stay than other cancer patients. Differences in outcomes suggest the need for targeted interventions to optimize hospice services for the hematologic malignancies population, especially those with leukemia.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Thomas W. MD, MA, Amy P. MD, PhD, David J. MD, MA,